Track record
Bihua Chen
An officer, director or large holder of 4 blank-check companies. Every role below was declared by Bihua Chen in an SEC ownership filing.
Vehicles
4
Still live
1
Closed a deal
3 of 3
Capital involved
$694M
Every vehicle, newest first
- Helix Acquisition Corp. IIIHLXC · Chairperson and CEO · IPO Jan 24, 2026$175MSearching
- BridgeBio Oncology Therapeutics, Inc.BBOT · CEO and Chairperson · IPO Feb 13, 2024$197MCompleted
- GreenLight Biosciences Holdings, PBC— · 10% holder · IPO Jan 15, 2021$207MCompleted
- MoonLake ImmunotherapeuticsMLTX · CEO and Chairman · IPO Oct 21, 2020$115MCompleted
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1599214. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.